Welcome !

Inserm U1070 “Pharmacology of Antimicrobial Agents is oriented towards Europe!

The research unit affiliated to the University of Poitiers and INSERM has been created in 2012 and comprises 20 permanent staff members (clinicians, pharmacists and scientists) and 13 students (PhD and master students).

The INSERM U1070 unit aim to optimize the antibiotic usage with a triple target:

  • To increase their efficacy,
  • To control the toxicity and
  • To limit the emergence of antibiotic resistance.

In order to do so, we are developping innovative PK/PD modelling approaches to select the best dosing regimen of antibiotics administered alone or in combination as well as the best route of administration and best formulation.

Inserm U1070 conducts translational research, from cells culture models to patients, by integrating microbiology, analytical chemistry, drug formulation, and in vivo preclinical experiments.

To date, Inserm U1070 received several grants from Region Nouvelle-Aquitaine, ANR, PHRC, JPIAMR, IMI and CPER-FEDER and has established collaborations with ANSES and several Universities in France (Paris Sud, Paris Diderot) and abroad (Dublin, Erasmus MC, Upssala, Hambourg, Catholic University of Louvain…), as well as leading pharmaceutical companies.


  • Follow us on